Effectiveness of medication review on the number of drug-related problems in patients visiting the outpatient cardiology clinic: A randomized controlled trial

被引:11
|
作者
Huiskes, Victor Johan Bernard [1 ]
van den Ende, Cornelia Helena Maria [2 ]
Kruijtbosch, Martine [3 ]
Ensing, Hendrik Tinus [4 ]
Meijs, Marieke [5 ]
Meijs, Veronique Maria Mathea [6 ]
Burger, David Marinus [7 ]
van den Bemt, Bartholomeus Johannes Fredericus [1 ,7 ,8 ]
机构
[1] Sint Maartensklin, Dept Pharm, Ubbergen, Netherlands
[2] Sint Maartensklin, Dept Rheumatol, Ubbergen, Netherlands
[3] SIR Inst Pharm Practice & Policy, Leiden, Netherlands
[4] Flevoziekenhuis, Outpatient Pharm, Almere, Netherlands
[5] St Antonius Hosp, Outpatient Pharm, Nieuwegein, Netherlands
[6] LUMC, Outpatient Pharm, Leiden, Netherlands
[7] Radboud Univ Nijmegen, Dept Pharm, Med Ctr, Nijmegen, Netherlands
[8] Maastricht Univ, Dept Clin Pharm & Toxicol, Med Ctr, Maastricht, Netherlands
关键词
clinical pharmacology; drug development; drug safety; drug utilization; prescribing; quality use of medicines; randomised controlled trial; ELDERLY-PATIENTS; SCREENING TOOL; ALERT DOCTORS; PRIMARY-CARE; PHARMACIST; OUTCOMES; ADMISSIONS; WARD;
D O I
10.1111/bcp.14125
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims To assess the effectiveness of medication review on the number of drug-related problems (DRPs) in outpatient cardiology patients. Methods In this randomized controlled trial, a computer-assisted and pharmacist-led medication review with patient involvement (questionnaire and telephone call with pharmacist) was conducted in intervention patients prior to their visit to the cardiologist. The control group received usual care. Adult outpatient cardiology patients without support concerning the administration of medication, without a medication review in the past 6 months and who gave permission to access their electronic medication record were included. The primary outcome measure was the number of DRPs 1 month after the visit. Secondary outcome measures concerned the type of DRP and the type of medication involved in the DRPs. Results In total, 75 patients (mean [standard deviation, SD] age 66.0 [12.5] years, 41% female) were included. Intervention (n = 90) and control group (n = 85) were comparable at baseline. The mean (SD) number of drugs used per patient was 7.9 (3.9). After 1 month, the mean (SD) number of DRPs was 0.3 (0.7) and 0.8 (1.0) and the median (range) number of DRPs was 0 (0-4) and 0 (0-4) in the intervention group and control group, respectively (P < .001). In the intervention group, 74% of the DRPs identified at T0 were solved at T1 vs 14% in the control group. Conclusion This randomized controlled trial suggests that a pharmacist-led medication review in patients with a scheduled visit to the outpatient cardiology clinic decreases the number of DRPs.
引用
收藏
页码:50 / 61
页数:12
相关论文
共 50 条
  • [21] Handling drug-related problems in rehabilitation patients: a randomized study
    Karin Willoch
    Hege Salvesen Blix
    Anne Marit Pedersen-Bjergaard
    Anne Kathrine Eek
    Aasmund Reikvam
    International Journal of Clinical Pharmacy, 2012, 34 : 382 - 388
  • [22] Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: a randomized controlled trial
    Pourrat, Xavier
    Roux, Clarisse
    Bouzige, Brigitte
    Garnier, Valerie
    Develay, Armelle
    Fraysse, Martial
    Halimi, Jean-Michel
    Allenet, Benoit
    Giraudeau, Bruno
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 212 - 213
  • [23] The contribution of patient interviews to the identification of drug-related problems in home medication review
    Kwint, H. F.
    Faber, A.
    Gussekloo, J.
    Bouvy, M. L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (06) : 674 - 680
  • [24] Drug-related problems identified during geriatric medication review in the community pharmacy
    Rhalimi, Mounir
    Rauss, Alain
    Housieaux, Eric
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 109 - 118
  • [25] Which patients should receive a medication review? Variables associated with the identification of drug-related problems during medication reviews
    Wuyts, Joke
    Maesschalck, Joris
    De Wulf, Isabelle
    De Lepeleire, Jan
    Foulon, Veerle
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (02) : 617 - 617
  • [26] Drug-related problems identified during geriatric medication review in the community pharmacy
    Mounir Rhalimi
    Alain Rauss
    Eric Housieaux
    International Journal of Clinical Pharmacy, 2018, 40 : 109 - 118
  • [27] Impact of pharmacist interventions on drug-related problems in general surgery patients: a randomised controlled trial
    AbuRuz, Salah
    Jaber, Deema
    Basheti, Iman
    Sadeq, Aya
    Arafat, Mosab
    AlAhmad, Mohammad
    Said, Amira
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (E1) : E72 - E78
  • [28] Effectiveness of an Integrated Multidisciplinary Osteoarthritis Outpatient Program versus Outpatient Clinic as Usual: A Randomized Controlled Trial
    Moe, Rikke Helene
    Grotle, Margreth
    Kjeken, Ingvild
    Olsen, Inge Christoffer
    Mowinckel, Petter
    Haavardsholm, Espen A.
    Hagen, Kare Birger
    Kvien, Tore K.
    Uhlig, Till
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (02) : 411 - 418
  • [29] MEDUCATE trial: effectiveness of an intensive EDUCATional intervention for IT-mediated MEDication management in the outpatient clinic – study protocol for a cluster randomized controlled trial
    F. van Stiphout
    J.E.F Zwart-van Rijkom
    J.E.C.M. Aarts
    H. Koffijberg
    E. Klarenbeek-deJonge
    M. Krulder
    K.C.B. Roes
    A.C.G. Egberts
    E.W.M.T. ter Braak
    Trials, 16
  • [30] Medication review software to improve the accuracy of outpatient medication histories: protocol for a randomized controlled trial
    Lesselroth, Blake J.
    Dorr, David A.
    Adams, Kathleen
    Church, Victoria
    Adams, Shawn
    Mazur, Dennis
    Russ, Yelizaveta
    Felder, Robert
    Douglas, David M.
    HUMAN FACTORS AND ERGONOMICS IN MANUFACTURING & SERVICE INDUSTRIES, 2012, 22 (01) : 72 - 86